[BOOK][B] Fundamentals of clinical trials

LM Friedman, CD Furberg, DL DeMets, DM Reboussin… - 2015 - Springer
The clinical trial is “the most definitive tool for evaluation of the applicability of clinical research.”
It represents “a key research activity with the potential to improve the quality of health …

The cardiovascular health study: design and rationale

LP Fried, NO Borhani, P Enright, CD Furberg… - Annals of …, 1991 - Elsevier
The Cardiovascular Health Study (CHS) is a population-based, longitudinal study of coronary
heart disease and stroke in adults aged 65 years and older. The main objective of the …

[HTML][HTML] Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

…, SA Shumaker, TE Snyder, CD Furberg… - … England Journal of …, 2000 - Mass Medical Soc
Background Heart disease is a major cause of illness and death in women. To understand
better the role of estrogen in the treatment and prevention of heart disease, more information …

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)

CD Furberg, BM Psaty, TA Manolio, JM Gardin… - The American journal of …, 1994 - Elsevier
Atrial fibrillation (AF) is a common arrhythmia in elderly persons and a common cause of
embolic stroke. Most studies of the prevalence and correlates of AF have used selected, hospital…

A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers

…, AD Oxman, S Treweek, CD Furberg… - Journal of clinical …, 2009 - Elsevier
OBJECTIVE: To propose a tool to assist trialists in making design decisions that are consistent
with their trial's stated purpose. STUDY DESIGN AND SETTING: Randomized trials have …

Incidence of and risk factors for atrial fibrillation in older adults

…, M Cushman, LP Fried, R White, CD Furberg… - Circulation, 1997 - Am Heart Assoc
Background This study aimed to describe the incidence of atrial fibrillation (AF) among older
adults during 3 years of follow-up. Methods and Results In this cohort study, 5201 adults ≥…

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of …

…, NS Abraham, EM Antman, FKL Chan, CD Furberg… - Circulation, 2008 - Am Heart Assoc
The use of antiplatelet therapies continues to increase as a result of accumulation of evidence
of benefits in both primary and secondary treatment strategies for cardiovascular disease. …

Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis

…, SR Heckbert, RN Lemaitre, EH Wagner, CD Furberg - Jama, 1997 - jamanetwork.com
Objective. —To review the scientific evidence concerning the safety and efficacy of various
antihypertensive therapies used as first-line agents and evaluated in terms of major disease …

Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association

LB Goldstein, R Adams, K Becker, CD Furberg… - Stroke, 2001 - Am Heart Assoc
Stroke ranks as the third leading cause of death in the United States. It is now estimated that
there are more than 700000 incident strokes annually and 4.4 million stroke survivors. 1, 2 …

Nifedipine: dose-related increase in mortality in patients with coronary heart disease

CD Furberg, BM Psaty, JV Meyer - Circulation, 1995 - Am Heart Assoc
Background The purpose of this study was to assess the effect of the dose of nifedipine, a
dihydropyridine calcium antagonist, on the increased risk of mortality seen in the randomized …